Microchips Biotech, Inc., formerly MicroCHIPS, Inc., today announced that recently named CEO, Cheryl Blanchard, Ph.D., will present at the East/West CEO Conference 2015, being held Jan. 10-11 in San Francisco. Dr. Blanchard will participate in a “Fireside Chat” panel discussion on Jan. 11 at 2:10 p.m. PST.
About Microchips Biotech, Inc.
Microchips Biotech, Inc. is dedicated to improving the lives of patients by revolutionizing drug delivery. The company’s proprietary platform technology is a microchip-based implant which can store and release precise doses of drugs at scheduled intervals for up to 16 years. The microchip-based implant has the potential to address significant unmet needs by simplifying dosing regimens and enhancing compliance for patients who need frequent dosing or require regular injections. Microchips Biotech is exploring potential applications for the microchip platform in female contraception, diabetes, osteoporosis and multiple sclerosis. Microchips Biotech was co-founded by renowned MIT researchers Robert Langer, Ph.D. and Michael J. Cima, Ph.D., and is funded by leading healthcare and technology venture investors including Polaris Partners, Medtronic, InterSouth, Flybridge Capital and InterWest.
